These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 5053009)

  • 1. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K; Hüdepohl M; Schopen RD
    Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
    Bannaski H
    Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunosuppresive treatment in chronic hepatitis and liver cirrhosis].
    Evers C; Hesch RD; Banzer D
    Med Welt; 1969 Feb; 8():415-21. PubMed ID: 4181608
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents].
    Bauch K; Büttner W; Lewicki I; Zimmermann S; Dempe A
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:169-72. PubMed ID: 4728086
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of chronic aggressive hepatitis with D-penicillamine].
    Lange J; Schumacher K; Witscher HP
    Dtsch Med Wochenschr; 1971 Jan; 96(4):139-45 passim. PubMed ID: 5539526
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of azathioprin in patients with cirrhosis of the liver.
    Ranek L; Schiödt T; Söborg M; Tygstrup N
    Scand J Gastroenterol Suppl; 1970; 7():49-54. PubMed ID: 4195441
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined form of chronic aggressive hepatitis primary biliary cirrhosis].
    Zimmermann K; Cueni B; Schmid M
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1749-52. PubMed ID: 929135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of immunoglobulins in the immunosuppressive therapy of liver diseases].
    Bauch K; Zimmermann S; Lewicki I; Büttner W
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2135-7. PubMed ID: 4650683
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of chronic hepatitis using immunosuppressive substances].
    Kommerell B; Seeliger M
    Dtsch Med Wochenschr; 1970 Dec; 95(50):2521-5. PubMed ID: 5484758
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive therapy of chronic aggressive hepatitis].
    Maleev A; Stojanov S
    Z Gesamte Inn Med; 1973 Oct; 28(20):Suppl:307-9. PubMed ID: 4767201
    [No Abstract]   [Full Text] [Related]  

  • 11. [Outlines for the use of immunosuppressive therapy in chronic aggressive hepatitis].
    Becker K
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):253. PubMed ID: 5055850
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunosuppressive drugs in the treatment of liver diseases (author's transl)].
    Magnenat P
    Ther Umsch; 1979 May; 36(5):432-8. PubMed ID: 451956
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive treatment of chronic hepatitis].
    Magyar I
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):31-4. PubMed ID: 5501423
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of blood immunoglobulins G,A,M,D in some liver diseases].
    Reil P; Halata J
    Vnitr Lek; 1973 Nov; 19(11):1093-8. PubMed ID: 4754616
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic hepatitis. A comparative study of the effect azathioprine and (+)-cyanidanol-3].
    Aguilar Reina J; de la Santa López J; Cuadras Avellana CM; Kern A
    Fortschr Med; 1978 Jan; 96(2):75-9. PubMed ID: 74352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up observations on chronic aggressive hepatitides during immunosuppressive therapy in a controlled study].
    Nicklis W; Kommerell B; Pfleiderer T
    Verh Dtsch Ges Inn Med; 1971; 77():1308-10. PubMed ID: 4949695
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of chronic hepatitis.
    Mistilis SP; Lam KC
    Prog Liver Dis; 1972; 4():419-32. PubMed ID: 4569006
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoglobulins A, G and M and selected biochemical parameters of the blood serum of patients with viral hepatitis and concomitant diseases].
    Patorska-Mach E; Modrzewska R; Pomorska M
    Wiad Lek; 1980 Jun; 33(12):945-9. PubMed ID: 7424001
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of immunoglobulins and the histological picture under immunosuppressive therapy in chronic liver diseases].
    Bauch K; Büttner W; Lewicki J; Dempe A; Zimmermann S
    Z Arztl Fortbild (Jena); 1973 Jul; 67(14):705-10. PubMed ID: 4774636
    [No Abstract]   [Full Text] [Related]  

  • 20. Extrahepatic malignancy in chronic liver disease: report of six cases.
    Viteri A; Vernace SJ; Schaffner F
    Gastroenterology; 1976 Dec; 71(6):1075-8. PubMed ID: 791743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.